These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30141204)

  • 1. Relationship Between Central Venous Catheter Protein Adsorption and Water Infused Surface Protection Mechanisms.
    Sutherland DW; Blanks ZD; Zhang X; Charest JL
    Artif Organs; 2018 Nov; 42(11):E369-E379. PubMed ID: 30141204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Water Infused Surface Protection as an Active Mechanism for Fibrin Sheath Prevention in Central Venous Catheters.
    Sutherland DW; Zhang X; Charest JL
    Artif Organs; 2017 Oct; 41(10):E155-E165. PubMed ID: 28744885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of oral anticoagulants to prevent central venous catheter-related thrombosis in hemodialysis].
    Mandolfo S; Gallieni M
    G Ital Nefrol; 2010; 27(5):490-7. PubMed ID: 20922680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium citrate 4% versus heparin as a lock solution in hemodialysis patients with central venous catheters.
    Yon CK; Low CL
    Am J Health Syst Pharm; 2013 Jan; 70(2):131-6. PubMed ID: 23292266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose versus high-dose heparin locks for hemodialysis catheters: a systematic review and meta-analysis.
    Han X; Yang X; Huang B; Yuan L; Cao Y
    Clin Nephrol; 2016 Jul; 86(7):1-8. PubMed ID: 27191662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular catheters with a nonleaching poly-sulfobetaine surface modification reduce thrombus formation and microbial attachment.
    Smith RS; Zhang Z; Bouchard M; Li J; Lapp HS; Brotske GR; Lucchino DL; Weaver D; Roth LA; Coury A; Biggerstaff J; Sukavaneshvar S; Langer R; Loose C
    Sci Transl Med; 2012 Sep; 4(153):153ra132. PubMed ID: 23019657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Temporary and permanent central venous catheters for hemodialysis].
    Premužić V; Tomašević B; Eržen G; Makar K; Brunetta-Gavranić B; Francetić I; Bašić-Jukić N; Kes P; Jelaković B
    Acta Med Croatica; 2014 Apr; 68(2):167-74. PubMed ID: 26012155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
    Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of intravenous heparin to prevent thrombosis of central venous catheter in children.
    Bracho-Blanchet E; Cortés-Sauza J; Dávila-Pérez R; Lezama-Del Valle P; Villalobos-Alfaro C; Nieto-Zermeño J
    Cir Cir; 2010; 78(5):423-9. PubMed ID: 21219813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of alternatives for dysfunctional double lumen central venous catheters using a two-compartmental mathematical model for different solutes.
    Van Canneyt K; Van Biesen W; Vanholder R; Segers P; Verdonck P; Eloot S
    Int J Artif Organs; 2013 Jan; 36(1):17-27. PubMed ID: 23280082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central venous catheter-related venous thrombosis in children with end-stage renal disease undergoing hemodialysis.
    Mandel-Shorer N; Tzvi-Behr S; Harvey E; Revel-Vilk S
    Thromb Res; 2018 Dec; 172():150-157. PubMed ID: 30414505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retained fibrin sheaths: chest computed tomography findings and clinical associations.
    Krausz DJ; Fisher JS; Rosen G; Haramati LB; Jain VR; Burton WB; Godelman A; Levsky JM; Taragin BH; Cynamon J; Aviram G
    J Thorac Imaging; 2014 Mar; 29(2):118-24. PubMed ID: 23846108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New technology: heparin and antimicrobial-coated catheters.
    Ibeas-Lopez J
    J Vasc Access; 2015; 16 Suppl 9():S48-53. PubMed ID: 25751551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occluded Tunneled Venous Catheter in Hemodialysis Patients: Risk Factors and Efficacy of Alteplase.
    Ponce D; Mendes M; Silva T; Oliveira R
    Artif Organs; 2015 Sep; 39(9):741-7. PubMed ID: 25894244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of fibrin in blood thrombi formed in hemodialysis central venous catheters: a pilot study on 43 CVCs.
    Lucas TC; Tessarolo F; Veniero P; D'Amato E; Caola I; Nollo G; Huebner R; Brunori G
    J Vasc Access; 2014; 15(4):278-85. PubMed ID: 24474517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convective Leakage Makes Heparin Locking of Central Venous Catheters Ineffective Within Seconds: Experimental Measurements in a Model Superior Vena Cava.
    Barbour MC; McGah PM; Ng CH; Clark AM; Gow KW; Aliseda A
    ASAIO J; 2015; 61(6):701-9. PubMed ID: 26418203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of infections and complications in central venous catheters in adults with solid tumours.
    Coady K; Ali M; Sidloff D; Kenningham RR; Ahmed S
    J Vasc Access; 2015; 16(1):38-41. PubMed ID: 25198809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters.
    Shah P; Shah V
    Cochrane Database Syst Rev; 2005 Jul; (3):CD002772. PubMed ID: 16034876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective use of alteplase for occluded tunneled venous catheter in hemodialysis patients.
    Mendes ML; Castro JH; Silva TN; Barretti P; Ponce D
    Artif Organs; 2014 May; 38(5):399-403. PubMed ID: 24117542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of complications related to central venous catheters in cancer patients: an update.
    Linnemann B
    Semin Thromb Hemost; 2014 Apr; 40(3):382-94. PubMed ID: 24595880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.